|
Corporate Presentation |
|
ECM Pharmacology Symposium |
|
Seladelpar Phase 2b-Histology-NASH-TAG 2021 |
|
Quantitative assessment of NASH pathologies in 152 baseline H&E slides from a Phase 2 trial using the Path AI machine learning algorithm |
|
AASLD - The Liver Meeting Presentation |
